GE Medical Systems
This article was originally published in The Gray Sheet
Executive SummaryReceives FDA clearance to market its digital radiography system optimized for chest exams. The system will sell for between $300,000 - $500,000. GEMS has invested more than 11 years and $130 mil. to develop the technology, which uses an amorphous silicon digital detector to directly display clinical images on a monitor "within seconds of the exam"
You may also be interested in...
After two Indian vaccine makers, Serum Institute of India and Cadila Healthcare joined the fight against COVID-19, Bharat Biotech may follow suit. Others like Hilleman have decided against it for the moment while Panacea Biotech is weighing the pros and cons of developing a SARS-CoV-2 vaccine after a sour experience with H1N1.
South Korea’s HLB has begun a new growth phase by taking over US-based clinical stage biotech firm Immunomic Therapeutics. Through the acquisition, it is poised to add new pipeline assets including a Phase II vaccine therapy for glioblastoma and proprietary lysosomal targeting technology.